ProVen Pharmaceuticals LLC

Braeburn Inc. is a Plymouth Meeting, PA-based company dedicated to addressing opioid use disorder through innovative products and community advocacy. With a strong focus on outreach, they aim to foster connections and support for individuals and families affected by substance use challenges. The organization emphasizes collaboration and partnerships to enhance the delivery of medicines and medical devices to U.S. patients. In addition, Braeburn actively participates in community initiatives, showcasing personal stories and promoting recovery-focused resources to reduce stigma around addiction. Generated from the website

AmerisourceBergen is one of the nation's largest pharmaceutical services providers. The company provides branded pharmaceuticals, generic pharmaceuticals, biotech and specialty drugs, over-the-counter remedies and health and beauty aids to independent retail pharmacies, national and regional chains, hospitals, clinics, pharmacy benefit managers, prescription mail order facilities, physician offices and long-term care facilities. AmerisourceBergen operates in two segments: pharmaceutical distribution, which includes the operations of AmerisourceBergen Drug Corporation, Specialty Group and Packaging Group; and PharMerica, which includes the long-term care pharmacy and workers' compensation businesses. The company has more than 14,000 employees. AmerisourceBergen began operations in August of 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. It is one of the largest pharmaceuticals distributors in the United States and has its headquarters in Valley Forge, Pa., and a Western management center in Orange, Calif. R. David Yost has been the chief executive officer of AmerisourceBergen for more than nine years. He has been with the medical and health care company for over 32 years. Yost earned a BS degree from the United States Air Force Academy, and a MBA from the University of California-Los Angeles. AmerisourceBergen has 43 distribution centers providing daily delivery in the United States.

CSL Behring is one of the leading providers of plasma protein biotherapeutic products in the world. It is a pharmaceutical company engaged in the research and development of life-saving biotherapies for the treatment of coagulation disorders, such as hemophilia and von Willebrand diseases. The company additionally manufactures a variety of medicines and drugs for the treatment of immune deficiencies, genetic emphysema, sepsis, severe burns, wounds and heomolytic diseases. It also provides medicines for transplantation, coagulation, immunology and critical care applications. The company supplies products under the Cytogam, Helixate, Humate-P, Monoclate-P, Mononine, Stimate, AlbuRx, Albuminar and Vivaglobin brands. It offers sales, marketing, distribution, online ordering and customer support services. The company maintains CSL Plasma, which is a plasma collection network that operates throughout the United States and Germany. CSL Behring is a part of CSL Limited, which is an Australia-based company that supplies sera and vaccines.